Put what only your company knows next to Sleuth Insights’ knowledge, in one system every team and agent can build on, with the security your company needs.
Most companies piece their market intelligence together: databases bought team by team, a knowledge graph built in house, fragmented consulting projects, and tools that don’t connect. Sleuth brings it into one system.
Trials, deals, filings, news, conferences, and analyst research, matched to the same companies, drugs, and targets, and updated as things change.
Bring in documents and data from Drive, SharePoint, Box, or your warehouse. Your programs show up next to everyone else’s.
Sleuth’s knowledge base follows industry-standard IDs and ontologies, so your team or your AI agents can connect your internal data to it without building a graph of your own.
Every team works from the same knowledge base, in Studio or in AI tools like Claude. Sleuth’s team sets it up around each team’s work.
Agents your team builds can use the same knowledge base, analysis, and documents your people use in Studio, through the API or MCP. Anything that supports MCP connects the same way.
Get results delivered to your warehouse on a schedule, and alerts in Slack or Microsoft Teams when something in a project changes.
Sleuth’s team trains each group on its own work and builds workflows and agents around the questions it brings every week.
Sleuth has a SOC 2 Type II report, encrypts your data, and keeps your company’s work private. Security reports, controls, and policies are in our Trust Center. Read the security overview.
Independently audited controls, monitored continuously. Request the report through the Trust Center.
Your data is encrypted in transit and at rest, and stored in the United States.
Your people sign in through your identity provider, with your own sign-in and MFA rules.
With the single-tenant option, you get a dedicated cloud account, your own Studio and API backend, and private storage, on the same knowledge base.
Your company’s questions, documents, and results stay private to your organization and are never pooled with other customers’ data. Sleuth deletes them on request.
Sleuth fills in your security questionnaire, and Enterprise comes with a custom MSA.
Enterprise customers get early access to data no one else has, from the early-stage companies, investors, and experts in Sleuth’s network. Your company’s own work is never part of it.
See what private, early-stage companies are building before they show up anywhere else.
Founders and experts sit down with Sleuth’s team to talk through their programs and markets, so you hear context that isn’t written anywhere.
See which targets and indications are suddenly drawing attention across the industry, before it shows up in deals or news.
At a global top-10 pharma, five teams run their research in Studio, so their time goes into the decisions instead of the data gathering.
Team
Their question
Competitive intelligence
“Which patients in this indication will matter most in five years, not just today?”
Search and evaluation
“Which of 412 exhibitors at a partnering event deserve our 20 meeting slots?”
External innovation
“Which UK investors back the kind of assets we want to in-license, and back them early?”
Business development
“Is a partner’s asking price for a Phase 2 asset defensible?”
R&D and manufacturing
“Which AI liver-toxicity vendors’ predictions hold up in real programs?”
Concierge puts Sleuth’s biopharma analysts on retainer for the questions that go to leadership. They work from the joint knowledge base your teams use, so each project builds on what your company already knows.
One retainer covers questions from every team as they come, from board prep to a partnering push, without scoping a new project each time.
Consultants ramp up from scratch on every project. Sleuth’s analysts start from the knowledge base your teams already share.
The report, the data, and the documents are saved to your Studio account, so any team can ask the next question itself.

“What makes Sleuth stand out is its rare combination of speed and credibility. The output is factual, well-structured, and decision-useful…”

Alex Cogdill
Head of Strategic Initiatives, Global BD, Daiichi Sankyo

“Sleuth told us how sure we could be about every value, with the reasoning and the sources.”

Dr. John Lambourne
Gene editing lead, Pencil Biosciences